Scan barcode
A review by lawbooks600
The Resistance by Gemma Malley
dark
medium-paced
- Plot- or character-driven? Plot
- Strong character development? No
- Loveable characters? Yes
- Diverse cast of characters? No
- Flaws of characters a main focus? It's complicated
3.0
Representation: N/A
Score: Six points out of ten.
One year ago, I read the first instalment of the Declaration trilogy, The Declaration. Unfortunately, it ultimately disappointed me. One year later, it was time to read the second part, The Resistance, which initially sounded promising. However, the author didn't improve her writing as she underwhelmed me again with this one. I should've lowered my expectations after seeing the low ratings and reviews.
It starts (more like continues) with the first character I see, Peter, whose surname I forgot, living in London after escaping from the Surplus Hall. After a few pages I soon observe Peter secretly entering the Pincent Pharma complex, the home of the immortal drug, Longevity, and surprisingly, his grandfather, Richard Pincent. They have a new drug in the works that promises to be even better than its predecessor: Longevity+, which uses stem cells to stop and reverse aging. However, it comes with a price; to be immortal, one cannot have children (their official names are Surpluses.) Peter abhors this idea because it only allows old people to live and no new people to be born as a measure of controlling the population. I was wondering how all the people are immortal, well now I know, but come on, stem cells? Really? Is that all it takes to cheat death? I don't believe that. This time the characters weren't annoying but boring and I couldn't connect or relate to them. The pacing was another weakness in The Resistance as the first 200 pages had nothing much happening in them, but the last 100 were faster paced and ended on a cliffhanger. The final part, The Legacy, is up next.
Score: Six points out of ten.
One year ago, I read the first instalment of the Declaration trilogy, The Declaration. Unfortunately, it ultimately disappointed me. One year later, it was time to read the second part, The Resistance, which initially sounded promising. However, the author didn't improve her writing as she underwhelmed me again with this one. I should've lowered my expectations after seeing the low ratings and reviews.
It starts (more like continues) with the first character I see, Peter, whose surname I forgot, living in London after escaping from the Surplus Hall. After a few pages I soon observe Peter secretly entering the Pincent Pharma complex, the home of the immortal drug, Longevity, and surprisingly, his grandfather, Richard Pincent. They have a new drug in the works that promises to be even better than its predecessor: Longevity+, which uses stem cells to stop and reverse aging. However, it comes with a price; to be immortal, one cannot have children (their official names are Surpluses.) Peter abhors this idea because it only allows old people to live and no new people to be born as a measure of controlling the population. I was wondering how all the people are immortal, well now I know, but come on, stem cells? Really? Is that all it takes to cheat death? I don't believe that. This time the characters weren't annoying but boring and I couldn't connect or relate to them. The pacing was another weakness in The Resistance as the first 200 pages had nothing much happening in them, but the last 100 were faster paced and ended on a cliffhanger. The final part, The Legacy, is up next.
Content Warnings
Graphic: Death and Pregnancy